<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>References | Multi-State Clinical Prediction Models in Renal Replacement Therapy</title>
  <meta name="description" content="References | Multi-State Clinical Prediction Models in Renal Replacement Therapy" />
  <meta name="generator" content="bookdown 0.21 and GitBook 2.6.7" />

  <meta property="og:title" content="References | Multi-State Clinical Prediction Models in Renal Replacement Therapy" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="References | Multi-State Clinical Prediction Models in Renal Replacement Therapy" />
  
  
  

<meta name="author" content="Michael Andrew Barrowman" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="chap-dev-paper-supp.html"/>

<style type="text/css">
p.abstract{
  text-align: center;
  font-weight: bold;
}
div.abstract{
  margin: auto;
  width: 90%;
}
</style>
<script src="libs/header-attrs-2.5/header-attrs.js"></script>
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />









<script src="libs/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="libs/anchor-sections-1.0/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0/anchor-sections.js"></script>
<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/lightable-0.0.1/lightable.css" rel="stylesheet" />
<link href="libs/bsTable-3.3.7/bootstrapTable.min.css" rel="stylesheet" />
<script src="libs/bsTable-3.3.7/bootstrapTable.js"></script>



</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Introduction</a>
<ul>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html#abstract"><i class="fa fa-check"></i>Abstract</a></li>
</ul></li>
<li class="chapter" data-level="1" data-path="chap-lit-report.html"><a href="chap-lit-report.html"><i class="fa fa-check"></i><b>1</b> Literature Report</a>
<ul>
<li class="chapter" data-level="1.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#introduction-1"><i class="fa fa-check"></i><b>1.1</b> Introduction</a></li>
<li class="chapter" data-level="1.2" data-path="chap-lit-report.html"><a href="chap-lit-report.html#clinical-prediction-models"><i class="fa fa-check"></i><b>1.2</b> Clinical Prediction Models</a>
<ul>
<li class="chapter" data-level="1.2.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#fundamental-prognosis-research"><i class="fa fa-check"></i><b>1.2.1</b> Fundamental Prognosis Research</a></li>
<li class="chapter" data-level="1.2.2" data-path="chap-lit-report.html"><a href="chap-lit-report.html#prognostic-factor-research"><i class="fa fa-check"></i><b>1.2.2</b> Prognostic Factor Research</a></li>
<li class="chapter" data-level="1.2.3" data-path="chap-lit-report.html"><a href="chap-lit-report.html#prognostic-model-research"><i class="fa fa-check"></i><b>1.2.3</b> Prognostic Model Research</a></li>
<li class="chapter" data-level="1.2.4" data-path="chap-lit-report.html"><a href="chap-lit-report.html#stratified-medicine"><i class="fa fa-check"></i><b>1.2.4</b> Stratified Medicine</a></li>
</ul></li>
<li class="chapter" data-level="1.3" data-path="chap-lit-report.html"><a href="chap-lit-report.html#competing-risks-multi-state-models"><i class="fa fa-check"></i><b>1.3</b> Competing Risks &amp; Multi-State Models</a>
<ul>
<li class="chapter" data-level="1.3.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#traditional-survival-analysis"><i class="fa fa-check"></i><b>1.3.1</b> Traditional Survival Analysis</a></li>
<li class="chapter" data-level="1.3.2" data-path="chap-lit-report.html"><a href="chap-lit-report.html#competing-risks"><i class="fa fa-check"></i><b>1.3.2</b> Competing Risks</a></li>
<li class="chapter" data-level="1.3.3" data-path="chap-lit-report.html"><a href="chap-lit-report.html#multi-state-models"><i class="fa fa-check"></i><b>1.3.3</b> Multi-State Models</a></li>
</ul></li>
<li class="chapter" data-level="1.4" data-path="chap-lit-report.html"><a href="chap-lit-report.html#chronic-kidney-disease"><i class="fa fa-check"></i><b>1.4</b> Chronic Kidney Disease</a>
<ul>
<li class="chapter" data-level="1.4.1" data-path="chap-lit-report.html"><a href="chap-lit-report.html#clinical-prediction-models-1"><i class="fa fa-check"></i><b>1.4.1</b> Clinical Prediction Models</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="2" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html"><i class="fa fa-check"></i><b>2</b> How Unmeasured Confounding in a Competing Risks Setting Can Affect Treatment Effect Estimates in Observational Studies</a>
<ul>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#abstract-1"><i class="fa fa-check"></i>Abstract</a>
<ul>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#background"><i class="fa fa-check"></i>Background</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#methods"><i class="fa fa-check"></i>Methods</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#results"><i class="fa fa-check"></i>Results</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#conclusion"><i class="fa fa-check"></i>Conclusion</a></li>
<li class="chapter" data-level="" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#supplementary-material"><i class="fa fa-check"></i>Supplementary Material</a></li>
</ul></li>
<li class="chapter" data-level="2.1" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#background-1"><i class="fa fa-check"></i><b>2.1</b> Background</a></li>
<li class="chapter" data-level="2.2" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#methods-1"><i class="fa fa-check"></i><b>2.2</b> Methods</a></li>
<li class="chapter" data-level="2.3" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#results-1"><i class="fa fa-check"></i><b>2.3</b> Results</a></li>
<li class="chapter" data-level="2.4" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#discussion"><i class="fa fa-check"></i><b>2.4</b> Discussion</a></li>
<li class="chapter" data-level="2.5" data-path="chap-Conf-CR.html"><a href="chap-Conf-CR.html#conclusion-1"><i class="fa fa-check"></i><b>2.5</b> Conclusion</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html"><i class="fa fa-check"></i><b>3</b> Using Inverse-Probability-of-Censoring-Weights to Estimate Calibration-in-the-Large for Time-to-Event Models</a>
<ul>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#abstract-2"><i class="fa fa-check"></i>Abstract</a>
<ul>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#introduction-2"><i class="fa fa-check"></i>Introduction</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#methods-2"><i class="fa fa-check"></i>Methods</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#results-2"><i class="fa fa-check"></i>Results</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#discussion-1"><i class="fa fa-check"></i>Discussion</a></li>
<li class="chapter" data-level="" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#supplementary-material-1"><i class="fa fa-check"></i>Supplementary Material</a></li>
</ul></li>
<li class="chapter" data-level="3.1" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#introduction-3"><i class="fa fa-check"></i><b>3.1</b> Introduction</a></li>
<li class="chapter" data-level="3.2" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#methods-3"><i class="fa fa-check"></i><b>3.2</b> Methods</a>
<ul>
<li class="chapter" data-level="3.2.1" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#aims"><i class="fa fa-check"></i><b>3.2.1</b> Aims</a></li>
<li class="chapter" data-level="3.2.2" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#data-generating-method"><i class="fa fa-check"></i><b>3.2.2</b> Data Generating Method</a></li>
<li class="chapter" data-level="3.2.3" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#prediction-models"><i class="fa fa-check"></i><b>3.2.3</b> Prediction Models</a></li>
<li class="chapter" data-level="3.2.4" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#the-ipcw"><i class="fa fa-check"></i><b>3.2.4</b> The IPCW</a></li>
<li class="chapter" data-level="3.2.5" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#calibration-measurements"><i class="fa fa-check"></i><b>3.2.5</b> Calibration Measurements</a></li>
<li class="chapter" data-level="3.2.6" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#estimands"><i class="fa fa-check"></i><b>3.2.6</b> Estimands</a></li>
<li class="chapter" data-level="3.2.7" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#performance-measures"><i class="fa fa-check"></i><b>3.2.7</b> Performance Measures</a></li>
<li class="chapter" data-level="3.2.8" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#software"><i class="fa fa-check"></i><b>3.2.8</b> Software</a></li>
</ul></li>
<li class="chapter" data-level="3.3" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#results-3"><i class="fa fa-check"></i><b>3.3</b> Results</a>
<ul>
<li class="chapter" data-level="3.3.1" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#no-correlation"><i class="fa fa-check"></i><b>3.3.1</b> No correlation</a></li>
<li class="chapter" data-level="3.3.2" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#positive-correlation"><i class="fa fa-check"></i><b>3.3.2</b> Positive correlation</a></li>
<li class="chapter" data-level="3.3.3" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#negative-correlation"><i class="fa fa-check"></i><b>3.3.3</b> Negative correlation</a></li>
</ul></li>
<li class="chapter" data-level="3.4" data-path="chap-IPCW-logistic.html"><a href="chap-IPCW-logistic.html#discussion-2"><i class="fa fa-check"></i><b>3.4</b> Discussion</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html"><i class="fa fa-check"></i><b>4</b> Prediction Model Performance Metrics for the Validation of Multi-State Clinical Prediction Models</a>
<ul>
<li class="chapter" data-level="4.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#introduction-4"><i class="fa fa-check"></i><b>4.1</b> Introduction</a></li>
<li class="chapter" data-level="4.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#motivating-data-set"><i class="fa fa-check"></i><b>4.2</b> Motivating Data Set</a></li>
<li class="chapter" data-level="4.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#current-approaches"><i class="fa fa-check"></i><b>4.3</b> Current Approaches</a>
<ul>
<li class="chapter" data-level="4.3.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#baseline-models"><i class="fa fa-check"></i><b>4.3.1</b> Baseline Models</a></li>
<li class="chapter" data-level="4.3.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#notation"><i class="fa fa-check"></i><b>4.3.2</b> Notation</a></li>
<li class="chapter" data-level="4.3.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#patient-weighting"><i class="fa fa-check"></i><b>4.3.3</b> Patient Weighting</a></li>
<li class="chapter" data-level="4.3.4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#accuracy---brier-score"><i class="fa fa-check"></i><b>4.3.4</b> Accuracy - Brier Score</a></li>
<li class="chapter" data-level="4.3.5" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discrimination---c-statistic"><i class="fa fa-check"></i><b>4.3.5</b> Discrimination - c-statistic</a></li>
<li class="chapter" data-level="4.3.6" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#calibration---intercept-and-slope"><i class="fa fa-check"></i><b>4.3.6</b> Calibration - Intercept and Slope</a></li>
</ul></li>
<li class="chapter" data-level="4.4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#extension-to-multi-state-models"><i class="fa fa-check"></i><b>4.4</b> Extension to Multi-State Models</a>
<ul>
<li class="chapter" data-level="4.4.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#trivial-extensions"><i class="fa fa-check"></i><b>4.4.1</b> Trivial Extensions</a></li>
<li class="chapter" data-level="4.4.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#accuracy---multiple-outcome-brier-score"><i class="fa fa-check"></i><b>4.4.2</b> Accuracy - Multiple Outcome Brier Score</a></li>
<li class="chapter" data-level="4.4.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discrimination---polytomous-discriminatory-index"><i class="fa fa-check"></i><b>4.4.3</b> Discrimination - Polytomous Discriminatory Index</a></li>
<li class="chapter" data-level="4.4.4" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#calibration---multinomial-intercept-matched-and-unmatched-slopes"><i class="fa fa-check"></i><b>4.4.4</b> Calibration - Multinomial Intercept, Matched and Unmatched Slopes</a></li>
</ul></li>
<li class="chapter" data-level="4.5" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#application-to-real-world-data"><i class="fa fa-check"></i><b>4.5</b> Application to Real-World Data</a>
<ul>
<li class="chapter" data-level="4.5.1" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#accuracy"><i class="fa fa-check"></i><b>4.5.1</b> Accuracy</a></li>
<li class="chapter" data-level="4.5.2" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discrimination"><i class="fa fa-check"></i><b>4.5.2</b> Discrimination</a></li>
<li class="chapter" data-level="4.5.3" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#calibration"><i class="fa fa-check"></i><b>4.5.3</b> Calibration</a></li>
</ul></li>
<li class="chapter" data-level="4.6" data-path="chap-performance-metrics.html"><a href="chap-performance-metrics.html#discussion-3"><i class="fa fa-check"></i><b>4.6</b> Discussion</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html"><i class="fa fa-check"></i><b>5</b> Development and External Validation of a Multi-State Clinical Prediction Model for Chronic Kidney Disease Patients Progressing onto Renal Replacement Therapy and Death</a>
<ul>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#abstract-3"><i class="fa fa-check"></i>Abstract</a>
<ul>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#objectives"><i class="fa fa-check"></i>Objectives</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#background-2"><i class="fa fa-check"></i>Background</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#objective"><i class="fa fa-check"></i>Objective</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#methods-4"><i class="fa fa-check"></i>Methods</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#results-4"><i class="fa fa-check"></i>Results</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#discusssion"><i class="fa fa-check"></i>Discusssion</a></li>
<li class="chapter" data-level="" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#supplementary-material-2"><i class="fa fa-check"></i>Supplementary Material</a></li>
</ul></li>
<li class="chapter" data-level="5.1" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#introduction-5"><i class="fa fa-check"></i><b>5.1</b> Introduction</a></li>
<li class="chapter" data-level="5.2" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#methods-5"><i class="fa fa-check"></i><b>5.2</b> Methods</a>
<ul>
<li class="chapter" data-level="5.2.1" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#data-sources"><i class="fa fa-check"></i><b>5.2.1</b> Data Sources</a></li>
<li class="chapter" data-level="5.2.2" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#model-design"><i class="fa fa-check"></i><b>5.2.2</b> Model Design</a></li>
<li class="chapter" data-level="5.2.3" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#validation"><i class="fa fa-check"></i><b>5.2.3</b> Validation</a></li>
<li class="chapter" data-level="5.2.4" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#example"><i class="fa fa-check"></i><b>5.2.4</b> Example</a></li>
<li class="chapter" data-level="5.2.5" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#calculator"><i class="fa fa-check"></i><b>5.2.5</b> Calculator</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#results-5"><i class="fa fa-check"></i><b>5.3</b> Results</a>
<ul>
<li class="chapter" data-level="5.3.1" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#data-sources-1"><i class="fa fa-check"></i><b>5.3.1</b> Data Sources</a></li>
<li class="chapter" data-level="5.3.2" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#development"><i class="fa fa-check"></i><b>5.3.2</b> Development</a></li>
<li class="chapter" data-level="5.3.3" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#validation-1"><i class="fa fa-check"></i><b>5.3.3</b> Validation</a></li>
<li class="chapter" data-level="5.3.4" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#example-1"><i class="fa fa-check"></i><b>5.3.4</b> Example</a></li>
<li class="chapter" data-level="5.3.5" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#calculator-1"><i class="fa fa-check"></i><b>5.3.5</b> Calculator</a></li>
</ul></li>
<li class="chapter" data-level="5.4" data-path="chap-dev-paper.html"><a href="chap-dev-paper.html#discussion-4"><i class="fa fa-check"></i><b>5.4</b> Discussion</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="chap-conclusion.html"><a href="chap-conclusion.html"><i class="fa fa-check"></i><b>6</b> Conclusion</a></li>
<li class="appendix"><span><b>Appendices</b></span></li>
<li class="chapter" data-level="A" data-path="chap-Conf-CR-supp.html"><a href="chap-Conf-CR-supp.html"><i class="fa fa-check"></i><b>A</b> How Unmeasured Confounding in a Competing Risks Setting Can Affect Treatment Effect Estimates in Observational Studies - Supplementary Material</a>
<ul>
<li class="chapter" data-level="A.1" data-path="chap-Conf-CR-supp.html"><a href="chap-Conf-CR-supp.html#chap-Conf-CR-supp-A"><i class="fa fa-check"></i><b>A.1</b> Simulation Details</a></li>
<li class="chapter" data-level="A.2" data-path="chap-Conf-CR-supp.html"><a href="chap-Conf-CR-supp.html#chap-Conf-CR-supp-B"><i class="fa fa-check"></i><b>A.2</b> Mathematics of Subdistribution Hazards</a></li>
</ul></li>
<li class="chapter" data-level="B" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html"><i class="fa fa-check"></i><b>B</b> Inverse Probability Weighting Adjustment of the Logistic Regression Calibration-in-the-Large - Supplementary Material</a>
<ul>
<li class="chapter" data-level="B.1" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html#calibration-slope"><i class="fa fa-check"></i><b>B.1</b> Calibration Slope</a>
<ul>
<li class="chapter" data-level="B.1.1" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html#results-6"><i class="fa fa-check"></i><b>B.1.1</b> Results</a></li>
<li class="chapter" data-level="B.1.2" data-path="chap-IPCW-logistic-supp.html"><a href="chap-IPCW-logistic-supp.html#discussion-5"><i class="fa fa-check"></i><b>B.1.2</b> Discussion</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="C" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html"><i class="fa fa-check"></i><b>C</b> Development and External Validation of a Multi-State Clinical Prediction Model for Chronic Kidney Disease Patients Progressing onto Renal Replacement Therapy and Death - Supplementary Material</a>
<ul>
<li class="chapter" data-level="C.1" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#statistical-analysis"><i class="fa fa-check"></i><b>C.1</b> Statistical Analysis</a>
<ul>
<li class="chapter" data-level="C.1.1" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#development-1"><i class="fa fa-check"></i><b>C.1.1</b> Development</a></li>
<li class="chapter" data-level="C.1.2" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#validation-2"><i class="fa fa-check"></i><b>C.1.2</b> Validation</a></li>
</ul></li>
<li class="chapter" data-level="C.2" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#model-results"><i class="fa fa-check"></i><b>C.2</b> Model Results</a>
<ul>
<li class="chapter" data-level="C.2.1" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#two-state-model"><i class="fa fa-check"></i><b>C.2.1</b> Two State Model</a></li>
<li class="chapter" data-level="C.2.2" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#three-state-model"><i class="fa fa-check"></i><b>C.2.2</b> Three State Model</a></li>
<li class="chapter" data-level="C.2.3" data-path="chap-dev-paper-supp.html"><a href="chap-dev-paper-supp.html#five-state-model"><i class="fa fa-check"></i><b>C.2.3</b> Five State Model</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Multi-State Clinical Prediction Models in Renal Replacement Therapy</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="references" class="section level1 unnumbered" number="">
<h1>References</h1>
<!--
This manually sets the header for this unnumbered chapter.
-->
<!--
To remove the indentation of the first entry.
-->
<p></p>
<!--
To create a hanging indent and spacing between entries.  These three lines may need to be removed for styles that don't require the hanging indent.
-->
<!--
This is just for testing with more citations for the bibliography at the end.  Add other entries into the list here if you'd like them to appear in the bibliography even if they weren't explicitly cited in the document.
-->
<div id="refs" class="references">
<div>
<p>[1] Hippocrates and F. Adams, <em>The genuine works of Hippocrates;</em> New York, W. Wood and company, 1886.</p>
</div>
<div>
<p>[2] J. Hippisley-Cox, C. Coupland, and P. Brindle, “Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study,” <em>BMJ</em>, vol. 357, May 2017, doi: <a href="https://doi.org/10.1136/bmj.j2099">10.1136/bmj.j2099</a>.</p>
</div>
<div>
<p>[3] H. Hemingway <em>et al.</em>, “Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes,” <em>BMJ</em>, vol. 346, p. e5595, Feb. 2013, doi: <a href="https://doi.org/10.1136/bmj.e5595">10.1136/bmj.e5595</a>.</p>
</div>
<div>
<p>[4] K. Thygesen, J. S. Alpert, H. D. White, and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, “Universal definition of myocardial infarction,” <em>Journal of the American College of Cardiology</em>, vol. 50, no. 22, pp. 2173–2195, Nov. 2007, doi: <a href="https://doi.org/10.1016/j.jacc.2007.09.011">10.1016/j.jacc.2007.09.011</a>.</p>
</div>
<div>
<p>[5] Probst <em>et al.</em>, “Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome,” <em>Circulation</em>, vol. 121, no. 5, pp. 635–643, Feb. 2010, doi: <a href="https://doi.org/10.1161/CIRCULATIONAHA.109.887026">10.1161/CIRCULATIONAHA.109.887026</a>.</p>
</div>
<div>
<p>[6] R. D. Riley, D. van der Windt, P. Croft, and K. G. M. Moons, <em>Prognosis Research in Healthcare: Concepts, Methods, and Impact</em>, First. Oxford University Press, 2019.</p>
</div>
<div>
<p>[7] R. D. Riley <em>et al.</em>, “Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research,” <em>PLoS Medicine</em>, vol. 10, no. 2, Feb. 2013, doi: <a href="https://doi.org/10.1371/journal.pmed.1001380">10.1371/journal.pmed.1001380</a>.</p>
</div>
<div>
<p>[8] E. W. Steyerberg <em>et al.</em>, “Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research,” <em>PLOS Medicine</em>, vol. 10, no. 2, p. e1001381, Feb. 2013, doi: <a href="https://doi.org/10.1371/journal.pmed.1001381">10.1371/journal.pmed.1001381</a>.</p>
</div>
<div>
<p>[9] P. Royston, K. G. M. Moons, D. G. Altman, and Y. Vergouwe, “Prognosis and prognostic research: Developing a prognostic model,” <em>BMJ</em>, vol. 338, p. b604, Mar. 2009, doi: <a href="https://doi.org/10.1136/bmj.b604">10.1136/bmj.b604</a>.</p>
</div>
<div>
<p>[10] D. G. Altman, Y. Vergouwe, P. Royston, and K. G. M. Moons, “Prognosis and prognostic research: Validating a prognostic model,” <em>BMJ</em>, vol. 338, p. b605, May 2009, doi: <a href="https://doi.org/10.1136/bmj.b605">10.1136/bmj.b605</a>.</p>
</div>
<div>
<p>[11] K. G. M. Moons, P. Royston, Y. Vergouwe, D. E. Grobbee, and D. G. Altman, “Prognosis and prognostic research: What, why, and how?” <em>BMJ</em>, vol. 338, p. b375, Feb. 2009, doi: <a href="https://doi.org/10.1136/bmj.b375">10.1136/bmj.b375</a>.</p>
</div>
<div>
<p>[12] A. D. Hingorani <em>et al.</em>, “Prognosis research strategy (PROGRESS) 4: Stratified medicine research,” <em>BMJ</em>, vol. 346, p. e5793, Feb. 2013, doi: <a href="https://doi.org/10.1136/bmj.e5793">10.1136/bmj.e5793</a>.</p>
</div>
<div>
<p>[13] G. S. Collins, J. B. Reitsma, D. G. Altman, and K. G. Moons, “Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement,” <em>BMC Medicine</em>, vol. 13, no. 1, p. 1, Jan. 2015, doi: <a href="https://doi.org/10.1186/s12916-014-0241-z">10.1186/s12916-014-0241-z</a>.</p>
</div>
<div>
<p>[14] K. G. M. Moons <em>et al.</em>, “Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration,” <em>Annals of Internal Medicine</em>, vol. 162, no. 1, p. W1, Jan. 2015, doi: <a href="https://doi.org/10.7326/M14-0698">10.7326/M14-0698</a>.</p>
</div>
<div>
<p>[15] R. D. Riley <em>et al.</em>, “External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: Opportunities and challenges,” <em>BMJ</em>, vol. 353, Jun. 2016, doi: <a href="https://doi.org/10.1136/bmj.i3140">10.1136/bmj.i3140</a>.</p>
</div>
<div>
<p>[16] G. S. Collins, O. Omar, M. Shanyinde, and L.-M. Yu, “A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods,” <em>Journal of Clinical Epidemiology</em>, vol. 66, no. 3, pp. 268–277, Mar. 2013, doi: <a href="https://doi.org/10.1016/j.jclinepi.2012.06.020">10.1016/j.jclinepi.2012.06.020</a>.</p>
</div>
<div>
<p>[17] E. W. Steyerberg, “Overfitting and optimism in prediction models,” in <em>Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating</em>, E. W. Steyerberg, Ed. New York, NY: Springer, 2009, pp. 83–100.</p>
</div>
<div>
<p>[18] P. Royston, D. G. Altman, and W. Sauerbrei, “Dichotomizing continuous predictors in multiple regression: A bad idea,” <em>Statistics in Medicine</em>, vol. 25, no. 1, pp. 127–141, Jan. 2006, doi: <a href="https://doi.org/10.1002/sim.2331">10.1002/sim.2331</a>.</p>
</div>
<div>
<p>[19] L. Chen, “Overview of clinical prediction models,” <em>Annals of Translational Medicine</em>, vol. 8, no. 4, Feb. 2020, doi: <a href="https://doi.org/10.21037/atm.2019.11.121">10.21037/atm.2019.11.121</a>.</p>
</div>
<div>
<p>[20] S. E. Bleeker <em>et al.</em>, “External validation is necessary in prediction research: A clinical example,” <em>Journal of Clinical Epidemiology</em>, vol. 56, no. 9, pp. 826–832, Sep. 2003, doi: <a href="https://doi.org/10.1016/s0895-4356(03)00207-5">10.1016/s0895-4356(03)00207-5</a>.</p>
</div>
<div>
<p>[21] S. B. Hanauer, “Exploring the controversial themes of IBD,” <em>Inflammatory Bowel Diseases</em>, vol. 15, no. S1, pp. S1–S10, 2009, doi: <a href="https://doi.org/10.1002/ibd.20945">10.1002/ibd.20945</a>.</p>
</div>
<div>
<p>[22] J. Hippisley-Cox <em>et al.</em>, “Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2,” <em>BMJ</em>, vol. 336, no. 7659, pp. 1475–1482, Jun. 2008, doi: <a href="https://doi.org/10.1136/bmj.39609.449676.25">10.1136/bmj.39609.449676.25</a>.</p>
</div>
<div>
<p>[23] P. Peduzzi, J. Concato, E. Kemper, T. R. Holford, and A. R. Feinstein, “A simulation study of the number of events per variable in logistic regression analysis,” <em>Journal of Clinical Epidemiology</em>, vol. 49, no. 12, pp. 1373–1379, Dec. 1996, doi: <a href="https://doi.org/10.1016/S0895-4356(96)00236-3">10.1016/S0895-4356(96)00236-3</a>.</p>
</div>
<div>
<p>[24] R. D. Riley <em>et al.</em>, “Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes,” <em>Statistics in Medicine</em>, vol. 38, no. 7, pp. 1276–1296, 2019, doi: <a href="https://doi.org/10.1002/sim.7992">10.1002/sim.7992</a>.</p>
</div>
<div>
<p>[25] W. Sauerbrei, P. Royston, and H. Binder, “Selection of important variables and determination of functional form for continuous predictors in multivariable model building,” <em>Statistics in Medicine</em>, vol. 26, no. 30, pp. 5512–5528, 2007, doi: <a href="https://doi.org/10.1002/sim.3148">10.1002/sim.3148</a>.</p>
</div>
<div>
<p>[26] Y. Vergouwe, E. W. Steyerberg, M. J. C. Eijkemans, and J. D. F. Habbema, “Substantial effective sample sizes were required for external validation studies of predictive logistic regression models,” <em>Journal of Clinical Epidemiology</em>, vol. 58, no. 5, pp. 475–483, May 2005, doi: <a href="https://doi.org/10.1016/j.jclinepi.2004.06.017">10.1016/j.jclinepi.2004.06.017</a>.</p>
</div>
<div>
<p>[27] C. Counsell and M. Dennis, “Systematic review of prognostic models in patients with acute stroke,” <em>Cerebrovascular Diseases (Basel, Switzerland)</em>, vol. 12, no. 3, pp. 159–170, 2001, doi: <a href="https://doi.org/10.1159/000047699">10.1159/000047699</a>.</p>
</div>
<div>
<p>[28] J. Ivanov, M. A. Borger, T. E. David, G. Cohen, N. Walton, and C. D. Naylor, “Predictive accuracy study: Comparing a statistical model to clinicians’ estimates of outcomes after coronary bypass surgery,” <em>The Annals of Thoracic Surgery</em>, vol. 70, no. 1, pp. 162–168, Jul. 2000, doi: <a href="https://doi.org/10.1016/s0003-4975(00)01387-4">10.1016/s0003-4975(00)01387-4</a>.</p>
</div>
<div>
<p>[29] J. Hippisley-Cox, C. Coupland, Y. Vinogradova, J. Robson, M. May, and P. Brindle, “Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study,” <em>BMJ (Clinical research ed.)</em>, vol. 335, no. 7611, p. 136, Jul. 2007, doi: <a href="https://doi.org/10.1136/bmj.39261.471806.55">10.1136/bmj.39261.471806.55</a>.</p>
</div>
<div>
<p>[30] J. L. Haybittle <em>et al.</em>, “A prognostic index in primary breast cancer.” <em>British Journal of Cancer</em>, vol. 45, no. 3, pp. 361–366, Mar. 1982.</p>
</div>
<div>
<p>[31] J. H. Todd <em>et al.</em>, “Confirmation of a prognostic index in primary breast cancer,” <em>British Journal of Cancer</em>, vol. 56, no. 4, pp. 489–492, Oct. 1987, doi: <a href="https://doi.org/10.1038/bjc.1987.230">10.1038/bjc.1987.230</a>.</p>
</div>
<div>
<p>[32] A. Pate, R. Emsley, D. M. Ashcroft, B. Brown, and T. van Staa, “The uncertainty with using risk prediction models for individual decision making: An exemplar cohort study examining the prediction of cardiovascular disease in English primary care,” <em>BMC Medicine</em>, vol. 17, no. 1, p. 134, Jul. 2019, doi: <a href="https://doi.org/10.1186/s12916-019-1368-8">10.1186/s12916-019-1368-8</a>.</p>
</div>
<div>
<p>[33] P. Bhatnagar, K. Wickramasinghe, J. Williams, M. Rayner, and N. Townsend, “The epidemiology of cardiovascular disease in the UK 2014,” <em>Heart</em>, vol. 101, no. 15, pp. 1182–1189, Aug. 2015, doi: <a href="https://doi.org/10.1136/heartjnl-2015-307516">10.1136/heartjnl-2015-307516</a>.</p>
</div>
<div>
<p>[34] D. A. Jenkins, M. Sperrin, G. P. Martin, and N. Peek, “Dynamic models to predict health outcomes: Current status and methodological challenges,” <em>Diagnostic and Prognostic Research</em>, vol. 2, no. 1, p. 23, Dec. 2018, doi: <a href="https://doi.org/10.1186/s41512-018-0045-2">10.1186/s41512-018-0045-2</a>.</p>
</div>
<div>
<p>[35] B. Liquet, J.-F. Timsit, and V. Rondeau, “Investigating hospital heterogeneity with a multi-state frailty model: Application to nosocomial pneumonia disease in intensive care units,” <em>BMC medical research methodology</em>, vol. 12, p. 79, Jun. 2012, doi: <a href="https://doi.org/10.1186/1471-2288-12-79">10.1186/1471-2288-12-79</a>.</p>
</div>
<div>
<p>[36] K. I. E. Snell <em>et al.</em>, “Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model,” <em>Journal of Clinical Epidemiology</em>, vol. 69, pp. 40–50, Jan. 2016, doi: <a href="https://doi.org/10.1016/j.jclinepi.2015.05.009">10.1016/j.jclinepi.2015.05.009</a>.</p>
</div>
<div>
<p>[37] J. Hippisley-Cox, C. Coupland, J. Robson, and P. M. Brindle, “Advantages of QRISK2 (2010): The key issue is ethnicity and extent of reallocation,” <em>Heart</em>, 2011, doi: <a href="https://doi.org/10.1136/hrt.2010.221085">10.1136/hrt.2010.221085</a>.</p>
</div>
<div>
<p>[38] L. Breiman, “Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author),” <em>Statistical Science</em>, vol. 16, no. 3, pp. 199–231, Aug. 2001, doi: <a href="https://doi.org/10.1214/ss/1009213726">10.1214/ss/1009213726</a>.</p>
</div>
<div>
<p>[39] D. R. Cox, “Regression Models and Life-Tables,” <em>Journal of the Royal Statistical Society: Series B (Methodological)</em>, vol. 34, no. 2, pp. 187–202, 1972, doi: <a href="https://doi.org/10.1111/j.2517-6161.1972.tb00899.x">10.1111/j.2517-6161.1972.tb00899.x</a>.</p>
</div>
<div>
<p>[40] T. M. Therneau and P. M. Grambsch, “The Cox Model,” in <em>Modeling Survival Data: Extending the Cox Model</em>, T. M. Therneau and P. M. Grambsch, Eds. New York, NY: Springer, 2000, pp. 39–77.</p>
</div>
<div>
<p>[41] P. Royston and M. K. B. Parmar, “Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects,” <em>Statistics in Medicine</em>, vol. 21, no. 15, pp. 2175–2197, Aug. 2002, doi: <a href="https://doi.org/10.1002/sim.1203">10.1002/sim.1203</a>.</p>
</div>
<div>
<p>[42] S. McKinley and M. Levine, “Cubic Spline Interpolation,” p. 15.</p>
</div>
<div>
<p>[43] R. C. Atkins, “The epidemiology of chronic kidney disease,” <em>Kidney International</em>, vol. 67, pp. S14–S18, Apr. 2005, doi: <a href="https://doi.org/10.1111/j.1523-1755.2005.09403.x">10.1111/j.1523-1755.2005.09403.x</a>.</p>
</div>
<div>
<p>[44] K. T. Mills <em>et al.</em>, “A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010,” <em>Kidney International</em>, vol. 88, no. 5, pp. 950–957, Nov. 2015, doi: <a href="https://doi.org/10.1038/ki.2015.230">10.1038/ki.2015.230</a>.</p>
</div>
<div>
<p>[45] J. Gilg, F. Caskey, and D. Fogarty, “UK Renal Registry 18th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2014: National and Centre-specific Analyses,” <em>Nephron</em>, vol. 132, no. Suppl. 1, pp. 9–40, 2016, doi: <a href="https://doi.org/10.1159/000444815">10.1159/000444815</a>.</p>
</div>
<div>
<p>[46] D. Ansell, T. Feest, C. Tomson, A. Williams, and G. Warwick, “9th Annual Report of the Renal Association,” <em>Nephrology Dialysis Transplantation</em>, 2007.</p>
</div>
<div>
<p>[47] A. J. Collins <em>et al.</em>, “US Renal Data System 2010 Annual Data Report,” <em>American Journal of Kidney Diseases</em>, vol. 57, no. 1, p. A8, Jan. 2011, doi: <a href="https://doi.org/10.1053/j.ajkd.2010.10.007">10.1053/j.ajkd.2010.10.007</a>.</p>
</div>
<div>
<p>[48] M. K. Tamura, J. C. Tan, and A. M. O’Hare, “Optimizing renal replacement therapy in older adults: A framework for making individualized decisions,” <em>Kidney International</em>, vol. 82, no. 3, pp. 261–269, Aug. 2012, doi: <a href="https://doi.org/10.1038/ki.2011.384">10.1038/ki.2011.384</a>.</p>
</div>
<div>
<p>[49] A. M. O’Hare, R. A. Rodriguez, S. M. Hailpern, E. B. Larson, and M. K. Tamura, “Regional Variation in Health Care Intensity and Treatment Practices for End-stage Renal Disease in Older Adults,” <em>JAMA</em>, vol. 304, no. 2, pp. 180–186, Jul. 2010, doi: <a href="https://doi.org/10.1001/jama.2010.924">10.1001/jama.2010.924</a>.</p>
</div>
<div>
<p>[50] Y.-C. Tina Shih, A. M. Y. Guo, P. M. Just, and S. Mujais, “Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients,” <em>Kidney International</em>, vol. 68, no. 1, pp. 319–329, Jul. 2005, doi: <a href="https://doi.org/10.1111/j.1523-1755.2005.00413.x">10.1111/j.1523-1755.2005.00413.x</a>.</p>
</div>
<div>
<p>[51] R. N. Foley, S.-C. CHEN, and A. J. Collins, “Hemodialysis access at initiation in the United States, 2005 to 2007: Still ‘catheter first’,” <em>Hemodialysis International</em>, vol. 13, no. 4, pp. 533–542, 2009.</p>
</div>
<div>
<p>[52] Vascular Access Work Group, “Clinical practice guidelines for vascular access,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 48 Suppl 1, pp. S248–273, Jul. 2006, doi: <a href="https://doi.org/10.1053/j.ajkd.2006.04.040">10.1053/j.ajkd.2006.04.040</a>.</p>
</div>
<div>
<p>[53] A. I. Richardson <em>et al.</em>, “Should fistulas really be first in the elderly patient?” <em>The journal of vascular access</em>, vol. 10, no. 3, pp. 199–202, 2009.</p>
</div>
<div>
<p>[54] J. Perl <em>et al.</em>, “Hemodialysis vascular access modifies the association between dialysis modality and survival,” <em>Journal of the American Society of Nephrology</em>, vol. 22, no. 6, pp. 1113–1121, 2011.</p>
</div>
<div>
<p>[55] R. Mehrotra, Y.-W. Chiu, K. Kalantar-Zadeh, J. Bargman, and E. Vonesh, “Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease,” <em>Archives of internal medicine</em>, vol. 171, no. 2, pp. 110–118, 2011.</p>
</div>
<div>
<p>[56] K. J. Jager, V. S. Stel, C. Wanner, C. Zoccali, and F. W. Dekker, “The valuable contribution of observational studies to nephrology,” <em>Kidney International</em>, vol. 72, no. 6, pp. 671–675, Sep. 2007, doi: <a href="https://doi.org/10.1038/sj.ki.5002397">10.1038/sj.ki.5002397</a>.</p>
</div>
<div>
<p>[57] P. M. Rothwell, “External validity of randomised controlled trials: ‘To whom do the results of this trial apply?” <em>Lancet</em>, vol. 365, 2005, doi: <a href="https://doi.org/10.1016/S0140-6736(04)17670-8">10.1016/S0140-6736(04)17670-8</a>.</p>
</div>
<div>
<p>[58] Z. Fewell, G. Davey Smith, and J. A. C. Sterne, “The impact of residual and unmeasured confounding in epidemiologic studies: A simulation study,” <em>Am J Epidemiol</em>, vol. 166, 2007, doi: <a href="https://doi.org/10.1093/aje/kwm165">10.1093/aje/kwm165</a>.</p>
</div>
<div>
<p>[59] N. X. Lin, S. Logan, and W. E. Henley, “Bias and sensitivity analysis when estimating treatment effects from the cox model with omitted covariates,” <em>Biometrics</em>, vol. 69, 2013, doi: <a href="https://doi.org/10.1111/biom.12096">10.1111/biom.12096</a>.</p>
</div>
<div>
<p>[60] G. K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, and D. Bull, “Cancer incidence and mortality in relation to body mass index in the million women study: Cohort study,” <em>BMJ</em>, vol. 335, 2007, doi: <a href="https://doi.org/10.1136/bmj.39367.495995.AE">10.1136/bmj.39367.495995.AE</a>.</p>
</div>
<div>
<p>[61] O. Klungsøyr, J. Sexton, I. Sandanger, and J. F. Nygård, “Sensitivity analysis for unmeasured confounding in a marginal structural Cox proportional hazards model,” <em>Lifetime Data Anal</em>, vol. 15, 2009, doi: <a href="https://doi.org/10.1007/s10985-008-9109-x">10.1007/s10985-008-9109-x</a>.</p>
</div>
<div>
<p>[62] R. M. Burne and M. Abrahamowicz, “Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data,” <em>Stat Methods Med Res</em>, vol. 0, 2017.</p>
</div>
<div>
<p>[63] W. Chen, X. Zhang, D. E. Faries, W. Shen, J. W. Seaman, and J. D. Stamey, “A Bayesian approach to correct for unmeasured or semi-unmeasured confounding in survival data using multiple validation data sets,” <em>Epidemiol Biostat Public Heal</em>, vol. 14, 2017.</p>
</div>
<div>
<p>[64] E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies,” <em>PLoS Med</em>, vol. 4, 2007, doi: <a href="https://doi.org/10.1371/journal.pmed.0040296">10.1371/journal.pmed.0040296</a>.</p>
</div>
<div>
<p>[65] K. B. Pouwels, N. N. Widyakusuma, R. H. H. Groenwold, and E. Hak, “Quality of reporting of confounding remained suboptimal after the STROBE guideline,” <em>J Clin Epidemiol</em>, vol. 69, 2016, doi: <a href="https://doi.org/10.1016/j.jclinepi.2015.08.009">10.1016/j.jclinepi.2015.08.009</a>.</p>
</div>
<div>
<p>[66] T. J. Vanderweele and P. Ding, “Sensitivity analysis in observational research: Introducing the E-value,” <em>Ann Intern Med Ann</em>, vol. 1677326, 2017, doi: <a href="https://doi.org/10.7326/M16-2607">10.7326/M16-2607</a>.</p>
</div>
<div>
<p>[67] M. T. Koller, H. Raatz, E. W. Steyerberg, and M. Wolbers, “Competing risks and the clinical community: Irrelevance or ignorance?” <em>Statistics in Medicine</em>, vol. 31, nos. 11-12, pp. 1089–1097, May 2012, doi: <a href="https://doi.org/10.1002/sim.4384">10.1002/sim.4384</a>.</p>
</div>
<div>
<p>[68] D. R. Cox and D. Oakes, <em>Analysis of survival data</em>. Cambridge: Chapman and Hall Ltd, 1984.</p>
</div>
<div>
<p>[69] J. P. Fine and R. J. Gray, “A Proportional Hazards Model for the Subdistribution of a Competing Risk,” <em>Journal of the American Statistical Association</em>, vol. 94, no. 446, pp. 496–509, 1999, doi: <a href="https://doi.org/10.2307/2670170">10.2307/2670170</a>.</p>
</div>
<div>
<p>[70] A. Burton, D. G. Altman, P. Royston, and R. L. Holder, “The design of simulation studies in medical statistics,” <em>Statistics in Medicine</em>, vol. 25, no. 24, pp. 4279–4292, Dec. 2006, doi: <a href="https://doi.org/10.1002/sim.2673">10.1002/sim.2673</a>.</p>
</div>
<div>
<p>[71] M. J. Crowther and P. C. Lambert, “Simulating biologically plausible complex survival data,” <em>Stat Med</em>, vol. 32, 2013, doi: <a href="https://doi.org/10.1002/sim.5823">10.1002/sim.5823</a>.</p>
</div>
<div>
<p>[72] B. Haller and K. Ulm, “Flexible simulation of competing risks data following prespecified subdistribution hazards,” <em>J Stat Comput Simul</em>, vol. 84, 2014, doi: <a href="https://doi.org/10.1080/00949655.2013.793345">10.1080/00949655.2013.793345</a>.</p>
</div>
<div>
<p>[73] whuber, “Generate a Gaussian and a binary random variables with predefined correlation,” <em>Cross Validated</em>. https://stats.stackexchange.com/a/313898/101156, Nov-2017.</p>
</div>
<div>
<p>[74] N. Grambauer, M. Schumacher, and J. Beyersmann, “Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified,” <em>Stat Med</em>, vol. 29, 2010, doi: <a href="https://doi.org/10.1002/sim.3786">10.1002/sim.3786</a>.</p>
</div>
<div>
<p>[75] A. Latouche, V. Boisson, S. Chevret, and R. Porcher, “Misspecified regression model for the subdistribution hazard of a competing risk.” <em>Statistics in Medicine</em>, vol. 26, no. 5, pp. 965–974, Feb. 2007, doi: <a href="https://doi.org/10.1002/sim.2600">10.1002/sim.2600</a>.</p>
</div>
<div>
<p>[76] M. H. Gail, S. Wieand, and S. Piantadosi, “Biased estimates of treatment effects in randomized experiments with nonlinear regression and omitted covariates,” <em>Biometrika</em>, vol. 71, 1984, doi: <a href="https://doi.org/10.1093/biomet/71.3.431">10.1093/biomet/71.3.431</a>.</p>
</div>
<div>
<p>[77] F. Mosteller, “A k-sample slippage test for an extreme population,” <em>Ann Math Stat</em>, vol. 19, 1948, doi: <a href="https://doi.org/10.1214/aoms/1177730290">10.1214/aoms/1177730290</a>.</p>
</div>
<div>
<p>[78] C. A. Thompson, Z.-F. Zhang, and O. A. Arah, “Competing risk bias to explain the inverse relationship between smoking and malignant melanoma,” <em>European Journal of Epidemiology</em>, vol. 28, no. 7, pp. 557–567, Jul. 2013, doi: <a href="https://doi.org/10.1007/s10654-013-9812-0">10.1007/s10654-013-9812-0</a>.</p>
</div>
<div>
<p>[79] F. Song, A. A. Qureshi, X. Gao, T. Li, and J. Han, “Smoking and risk of skin cancer: A prospective analysis and a meta-analysis,” <em>Int J Epidemiol</em>, vol. 41, 2012, doi: <a href="https://doi.org/10.1093/ije/dys146">10.1093/ije/dys146</a>.</p>
</div>
<div>
<p>[80] R. o. l. f. H. H. Groenwold, D. a. v. i. d. B. Nelson, K. r. i. s. t. i. n. L. Nichol, A. r. n. o. W. Hoes, and E. e. l. k. o. Hak, “Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research,” <em>International Journal of Epidemiology</em>, vol. 39, 2009, doi: <a href="https://doi.org/10.1093/ije/dyp332">10.1093/ije/dyp332</a>.</p>
</div>
<div>
<p>[81] M. M. Suttorp, B. Siegerink, K. J. Jager, C. Zoccali, and F. W. Dekker, “Graphical presentation of confounding in directed acyclic graphs,” <em>Nephrol Dial Transplant</em>, vol. 30, 2015, doi: <a href="https://doi.org/10.1093/ndt/gfu325">10.1093/ndt/gfu325</a>.</p>
</div>
<div>
<p>[82] H. Putter, M. Fiocco, and R. B. Geskus, “Tutorial in biostatistics: Competing risks and multi-state models,” <em>Statistics in Medicine</em>, vol. 26, no. 11, pp. 2389–2430, May 2007, doi: <a href="https://doi.org/10.1002/sim.2712">10.1002/sim.2712</a>.</p>
</div>
<div>
<p>[83] D. Y. Lin and L. J. Wei, “The robust inference for the Cox proportional hazards model,” <em>J Am Stat Assoc</em>, vol. 84, 1989, doi: <a href="https://doi.org/10.1080/01621459.1989.10478874">10.1080/01621459.1989.10478874</a>.</p>
</div>
<div>
<p>[84] C. R. Lesko and B. Lau, “Bias Due to Confounders for the Exposure-Competing Risk Relationship,” <em>Epidemiology (Cambridge, Mass.)</em>, vol. 28, no. 1, pp. 20–27, Jan. 2017, doi: <a href="https://doi.org/10.1097/EDE.0000000000000565">10.1097/EDE.0000000000000565</a>.</p>
</div>
<div>
<p>[85] E. W. Steyerberg, <em>Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating</em>. Springer Science &amp; Business Media, 2008.</p>
</div>
<div>
<p>[86] B. V. Calster, D. Nieboer, Y. Vergouwe, B. D. Cock, M. J. Pencina, and E. W. Steyerberg, “A calibration hierarchy for risk models was defined: From utopia to empirical data,” <em>Journal of Clinical Epidemiology</em>, vol. 74, pp. 167–176, Jun. 2016, doi: <a href="https://doi.org/10.1016/j.jclinepi.2015.12.005">10.1016/j.jclinepi.2015.12.005</a>.</p>
</div>
<div>
<p>[87] C. S. Crowson, E. J. Atkinson, and T. M. Therneau, “Assessing Calibration of Prognostic Risk Scores,” <em>Statistical methods in medical research</em>, vol. 25, no. 4, pp. 1692–1706, Aug. 2016, doi: <a href="https://doi.org/10.1177/0962280213497434">10.1177/0962280213497434</a>.</p>
</div>
<div>
<p>[88] P. Royston and D. G. Altman, “External validation of a Cox prognostic model: Principles and methods,” <em>BMC Medical Research Methodology</em>, vol. 13, no. 1, p. 33, Mar. 2013, doi: <a href="https://doi.org/10.1186/1471-2288-13-33">10.1186/1471-2288-13-33</a>.</p>
</div>
<div>
<p>[89] D. C. Goff <em>et al.</em>, “2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” <em>Circulation</em>, vol. 129, no. 25 suppl 2, pp. S49–S73, Jun. 2014, doi: <a href="https://doi.org/10.1161/01.cir.0000437741.48606.98">10.1161/01.cir.0000437741.48606.98</a>.</p>
</div>
<div>
<p>[90] B. de la Iglesia, J. F. Potter, N. R. Poulter, M. M. Robins, and J. Skinner, “Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice,” <em>Heart</em>, vol. 97, no. 6, pp. 491–499, Mar. 2011, doi: <a href="https://doi.org/10.1136/hrt.2010.203364">10.1136/hrt.2010.203364</a>.</p>
</div>
<div>
<p>[91] P. Royston, “Tools for Checking Calibration of a Cox Model in External Validation: Approach Based on Individual Event Probabilities:” <em>The Stata Journal</em>, Dec. 2014, doi: <a href="https://doi.org/10.1177/1536867X1401400403">10.1177/1536867X1401400403</a>.</p>
</div>
<div>
<p>[92] P. Royston, “Tools for Checking Calibration of a Cox Model in External Validation: Prediction of Population-Averaged Survival Curves Based on Risk Groups,” <em>The Stata Journal</em>, vol. 15, no. 1, pp. 275–291, Apr. 2015, doi: <a href="https://doi.org/10.1177/1536867X1501500116">10.1177/1536867X1501500116</a>.</p>
</div>
<div>
<p>[93] M. P. Perme and P. K. Andersen, “Checking hazard regression models using pseudo-observations,” <em>Statistics in medicine</em>, vol. 27, no. 25, pp. 5309–5328, Nov. 2008, doi: <a href="https://doi.org/10.1002/sim.3401">10.1002/sim.3401</a>.</p>
</div>
<div>
<p>[94] T. A. Gerds and M. Schumacher, “Consistent Estimation of the Expected Brier Score in General Survival Models with Right-Censored Event Times,” <em>Biometrical Journal</em>, vol. 48, no. 6, pp. 1029–1040, 2006, doi: <a href="https://doi.org/10.1002/bimj.200610301">10.1002/bimj.200610301</a>.</p>
</div>
<div>
<p>[95] C. Spitoni, V. Lammens, and H. Putter, “Prediction errors for state occupation and transition probabilities in multi-state models,” <em>Biometrical Journal. Biometrische Zeitschrift</em>, vol. 60, no. 1, pp. 34–48, Jan. 2018, doi: <a href="https://doi.org/10.1002/bimj.201600191">10.1002/bimj.201600191</a>.</p>
</div>
<div>
<p>[96] X. Han, Y. Zhang, and Y. Shao, “On comparing two correlated C indices with censored survival data,” <em>Statistics in medicine</em>, vol. 36, no. 25, pp. 4041–4049, Nov. 2017, doi: <a href="https://doi.org/10.1002/sim.7414">10.1002/sim.7414</a>.</p>
</div>
<div>
<p>[97] X. Liu, Z. Jin, and J. H. Graziano, “Comparing paired biomarkers in predicting quantitative health outcome subject to random censoring,” <em>Statistical methods in medical research</em>, vol. 25, no. 1, pp. 447–457, Feb. 2016, doi: <a href="https://doi.org/10.1177/0962280212460434">10.1177/0962280212460434</a>.</p>
</div>
<div>
<p>[98] X. Shu and D. E. Schaubel, “Methods for Contrasting Gap Time Hazard Functions: Application to Repeat Liver Transplantation,” <em>Statistics in biosciences</em>, vol. 9, no. 2, pp. 470–488, Dec. 2017, doi: <a href="https://doi.org/10.1007/s12561-016-9168-6">10.1007/s12561-016-9168-6</a>.</p>
</div>
<div>
<p>[99] P. K. Andersen and M. Pohar Perme, “Pseudo-observations in survival analysis,” <em>Statistical Methods in Medical Research</em>, vol. 19, no. 1, pp. 71–99, Feb. 2010, doi: <a href="https://doi.org/10.1177/0962280209105020">10.1177/0962280209105020</a>.</p>
</div>
<div>
<p>[100] R. C. Team, “R: A Language and Environment for Statistical Computing.” R Foundation for Statistical Computing, Vienna, Austria, Vienna,</p>
</div>
<div>
<p>[101] H. Wickham, “The tidy tools manifesto.” https://cran.r-project.org/web/packages/tidyverse/vignettes/manifesto.html, Nov-2017.</p>
</div>
<div>
<p>[102] T. Therneau, “A package for survival analysis in R,” p. 89, Mar. 2020.</p>
</div>
<div>
<p>[103] D. Eddelbuettel and R. Francois, “Rcpp: Seamless R and C++ Integration,” <em>Journal of Statistical Software</em>, vol. 40, no. 1, pp. 1–18, Apr. 2011, doi: <a href="https://doi.org/10.18637/jss.v040.i08">10.18637/jss.v040.i08</a>.</p>
</div>
<div>
<p>[104] M. P. Perme, M. Gerster, and K. Rodrigues, “Pseudo: Computes Pseudo-Observations for Modeling.” Jul-2017.</p>
</div>
<div>
<p>[105] W. Chang <em>et al.</em>, “Shiny: Web Application Framework for R.” Mar-2020.</p>
</div>
<div>
<p>[106] E. W. Steyerberg and Y. Vergouwe, “Towards better clinical prediction models: Seven steps for development and an ABCD for validation,” <em>European Heart Journal</em>, vol. 35, no. 29, pp. 1925–1931, Aug. 2014, doi: <a href="https://doi.org/10.1093/eurheartj/ehu207">10.1093/eurheartj/ehu207</a>.</p>
</div>
<div>
<p>[107] G. W. Brier, “Verification of forecasts expressed in terms of probability,” <em>Monthly Weather Review</em>, vol. 78, no. 1, pp. 1–3, Jan. 1950, doi: <a href="https://doi.org/10.1175/1520-0493(1950)078%3C0001:VOFEIT%3E2.0.CO;2">10.1175/1520-0493(1950)078&lt;0001:VOFEIT&gt;2.0.CO;2</a>.</p>
</div>
<div>
<p>[108] K. V. Hoorde, Y. Vergouwe, D. Timmerman, S. V. Huffel, E. W. Steyerberg, and B. V. Calster, “Assessing calibration of multinomial risk prediction models,” <em>Statistics in Medicine</em>, vol. 33, no. 15, pp. 2585–2596, Jul. 2014, doi: <a href="https://doi.org/10.1002/sim.6114">10.1002/sim.6114</a>.</p>
</div>
<div>
<p>[109] B. V. Calster, V. V. Belle, Y. Vergouwe, D. Timmerman, S. V. Huffel, and E. W. Steyerberg, “Extending the c-statistic to nominal polytomous outcomes: The Polytomous Discrimination Index,” <em>Statistics in Medicine</em>, vol. 31, no. 23, pp. 2610–2626, 2012, doi: <a href="https://doi.org/10.1002/sim.5321">10.1002/sim.5321</a>.</p>
</div>
<div>
<p>[110] M. Schumacher, E. Graf, and T. Gerds, “How to assess prognostic models for survival data: A case study in oncology,” <em>Methods of Information in Medicine</em>, vol. 42, no. 5, pp. 564–571, 2003.</p>
</div>
<div>
<p>[111] Y. Matsuyama and T. Yamaguchi, “Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods,” <em>Pharmaceutical Statistics</em>, vol. 7, no. 3, pp. 202–214, 2008, doi: <a href="https://doi.org/10.1002/pst.290">10.1002/pst.290</a>.</p>
</div>
<div>
<p>[112] D. C. Montgomery and G. C. Runger, <em>Applied statistics and probability for engineers</em>, 3rd ed. New York: Wiley, 2003.</p>
</div>
<div>
<p>[113] P. C. Austin and E. W. Steyerberg, “Interpreting the concordance statistic of a logistic regression model: Relation to the variance and odds ratio of a continuous explanatory variable,” <em>BMC Medical Research Methodology</em>, vol. 12, no. 1, p. 82, Jun. 2012, doi: <a href="https://doi.org/10.1186/1471-2288-12-82">10.1186/1471-2288-12-82</a>.</p>
</div>
<div>
<p>[114] B. Ripley and W. Venables, “Package ’nnet’,” Feb-2016.</p>
</div>
<div>
<p>[115] K. J. Arrow, <em>Social Choice and Individual Values: Third Edition</em>. Yale University Press, 2012.</p>
</div>
<div>
<p>[116] E. S. Johnson, M. L. Thorp, X. Yang, O. L. Charansonney, and D. H. Smith, “Predicting renal replacement therapy and mortality in CKD,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 50, no. 4, pp. 559–565, Oct. 2007, doi: <a href="https://doi.org/10.1053/j.ajkd.2007.07.006">10.1053/j.ajkd.2007.07.006</a>.</p>
</div>
<div>
<p>[117] M. J. Landray <em>et al.</em>, “Prediction of ESRD and death among people with CKD: The Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 56, no. 6, pp. 1082–1094, Dec. 2010, doi: <a href="https://doi.org/10.1053/j.ajkd.2010.07.016">10.1053/j.ajkd.2010.07.016</a>.</p>
</div>
<div>
<p>[118] N. Bansal <em>et al.</em>, “Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD,” <em>Clinical journal of the American Society of Nephrology: CJASN</em>, vol. 10, no. 3, pp. 363–371, Mar. 2015, doi: <a href="https://doi.org/10.2215/CJN.04650514">10.2215/CJN.04650514</a>.</p>
</div>
<div>
<p>[119] A. Marks <em>et al.</em>, “Looking to the future: Predicting renal replacement outcomes in a large community cohort with chronic kidney disease,” <em>Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association</em>, vol. 30, no. 9, pp. 1507–1517, Sep. 2015, doi: <a href="https://doi.org/10.1093/ndt/gfv089">10.1093/ndt/gfv089</a>.</p>
</div>
<div>
<p>[120] J. P. Wick <em>et al.</em>, “A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 69, no. 5, pp. 568–575, May 2017, doi: <a href="https://doi.org/10.1053/j.ajkd.2016.08.035">10.1053/j.ajkd.2016.08.035</a>.</p>
</div>
<div>
<p>[121] E. S. Johnson, M. L. Thorp, R. W. Platt, and D. H. Smith, “Predicting the risk of dialysis and transplant among patients with CKD: A retrospective cohort study,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 52, no. 4, pp. 653–660, Oct. 2008, doi: <a href="https://doi.org/10.1053/j.ajkd.2008.04.026">10.1053/j.ajkd.2008.04.026</a>.</p>
</div>
<div>
<p>[122] E. B. Schroeder <em>et al.</em>, “Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation,” <em>Clinical journal of the American Society of Nephrology: CJASN</em>, vol. 12, no. 1, pp. 87–94, Jun. 2017, doi: <a href="https://doi.org/10.2215/CJN.01290216">10.2215/CJN.01290216</a>.</p>
</div>
<div>
<p>[123] S. Kulkarni <em>et al.</em>, “Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling,” <em>PLOS ONE</em>, vol. 12, no. 12, p. e0190277, Dec. 2017, doi: <a href="https://doi.org/10.1371/journal.pone.0190277">10.1371/journal.pone.0190277</a>.</p>
</div>
<div>
<p>[124] J. Floege <em>et al.</em>, “Development and validation of a predictive mortality risk score from a European hemodialysis cohort,” <em>Kidney International</em>, vol. 87, no. 5, pp. 996–1008, May 2015, doi: <a href="https://doi.org/10.1038/ki.2014.419">10.1038/ki.2014.419</a>.</p>
</div>
<div>
<p>[125] A. C. Hemke, M. B. Heemskerk, M. van Diepen, W. Weimar, F. W. Dekker, and A. J. Hoitsma, “Survival prognosis after the start of a renal replacement therapy in the Netherlands: A retrospective cohort study,” <em>BMC Nephrology</em>, vol. 14, p. 258, Nov. 2013, doi: <a href="https://doi.org/10.1186/1471-2369-14-258">10.1186/1471-2369-14-258</a>.</p>
</div>
<div>
<p>[126] X.-Y. Cao <em>et al.</em>, “Predicting one-year mortality in peritoneal dialysis patients: An analysis of the China Peritoneal Dialysis Registry,” <em>International Journal of Medical Sciences</em>, vol. 12, no. 4, pp. 354–361, 2015, doi: <a href="https://doi.org/10.7150/ijms.11694">10.7150/ijms.11694</a>.</p>
</div>
<div>
<p>[127] N. Tangri <em>et al.</em>, “A predictive model for progression of chronic kidney disease to kidney failure,” <em>JAMA</em>, vol. 305, no. 15, pp. 1553–1559, Apr. 2011, doi: <a href="https://doi.org/10.1001/jama.2011.451">10.1001/jama.2011.451</a>.</p>
</div>
<div>
<p>[128] J. Roy <em>et al.</em>, “Statistical Methods for Cohort Studies of CKD: Prediction Modeling,” <em>Clinical journal of the American Society of Nephrology: CJASN</em>, vol. 12, no. 6, pp. 1010–1017, Jun. 2017, doi: <a href="https://doi.org/10.2215/CJN.06210616">10.2215/CJN.06210616</a>.</p>
</div>
<div>
<p>[129] N. Tangri <em>et al.</em>, “A Dynamic Predictive Model for Progression of CKD,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 69, no. 4, pp. 514–520, Apr. 2017, doi: <a href="https://doi.org/10.1053/j.ajkd.2016.07.030">10.1053/j.ajkd.2016.07.030</a>.</p>
</div>
<div>
<p>[130] M. G. Shlipak <em>et al.</em>, “Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors,” <em>JAMA</em>, vol. 293, no. 14, pp. 1737–1745, Apr. 2005, doi: <a href="https://doi.org/10.1001/jama.293.14.1737">10.1001/jama.293.14.1737</a>.</p>
</div>
<div>
<p>[131] D. E. Weiner <em>et al.</em>, “The Framingham predictive instrument in chronic kidney disease,” <em>Journal of the American College of Cardiology</em>, vol. 50, no. 3, pp. 217–224, Jul. 2007, doi: <a href="https://doi.org/10.1016/j.jacc.2007.03.037">10.1016/j.jacc.2007.03.037</a>.</p>
</div>
<div>
<p>[132] J. J. V. McMurray <em>et al.</em>, “Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT),” <em>American Heart Journal</em>, vol. 162, no. 4, pp. 748–755.e3, Oct. 2011, doi: <a href="https://doi.org/10.1016/j.ahj.2011.07.016">10.1016/j.ahj.2011.07.016</a>.</p>
</div>
<div>
<p>[133] M. E. Grams and J. Coresh, “Assessing risk in chronic kidney disease: A methodological review,” <em>Nature Reviews. Nephrology</em>, vol. 9, no. 1, pp. 18–25, Jan. 2013, doi: <a href="https://doi.org/10.1038/nrneph.2012.248">10.1038/nrneph.2012.248</a>.</p>
</div>
<div>
<p>[134] N. Tangri <em>et al.</em>, “Risk prediction models for patients with chronic kidney disease: A systematic review,” <em>Annals of Internal Medicine</em>, vol. 158, no. 8, pp. 596–603, Apr. 2013, doi: <a href="https://doi.org/10.7326/0003-4819-158-8-201304160-00004">10.7326/0003-4819-158-8-201304160-00004</a>.</p>
</div>
<div>
<p>[135] C. L. Ramspek, P. W. Voskamp, F. J. van Ittersum, R. T. Krediet, F. W. Dekker, and M. van Diepen, “Prediction models for the mortality risk in chronic dialysis patients: A systematic review and independent external validation study,” <em>Clinical Epidemiology</em>, vol. 9, pp. 451–464, 2017, doi: <a href="https://doi.org/10.2147/CLEP.S139748">10.2147/CLEP.S139748</a>.</p>
</div>
<div>
<p>[136] W. Bouwmeester <em>et al.</em>, “Reporting and Methods in Clinical Prediction Research: A Systematic Review,” <em>PLOS Medicine</em>, vol. 9, no. 5, p. e1001221, May 2012, doi: <a href="https://doi.org/10.1371/journal.pmed.1001221">10.1371/journal.pmed.1001221</a>.</p>
</div>
<div>
<p>[137] A. Perotte, R. Ranganath, J. S. Hirsch, D. Blei, and N. Elhadad, “Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis,” <em>Journal of the American Medical Informatics Association: JAMIA</em>, vol. 22, no. 4, pp. 872–880, Jul. 2015, doi: <a href="https://doi.org/10.1093/jamia/ocv024">10.1093/jamia/ocv024</a>.</p>
</div>
<div>
<p>[138] A. Begun, A. Icks, R. Waldeyer, S. Landwehr, M. Koch, and G. Giani, “Identification of a multistate continuous-time nonhomogeneous Markov chain model for patients with decreased renal function.” <em>Medical decision making : an international journal of the Society for Medical Decision Making</em>, vol. 33, no. 2, pp. 298–306, Feb. 2013, doi: <a href="https://doi.org/10.1177/0272989X12466731">10.1177/0272989X12466731</a>.</p>
</div>
<div>
<p>[139] A. M. Allen, W. R. Kim, T. M. Therneau, J. J. Larson, J. K. Heimbach, and A. D. Rule, “Chronic kidney disease and associated mortality after liver transplantation–a time-dependent analysis using measured glomerular filtration rate,” <em>Journal of Hepatology</em>, vol. 61, no. 2, pp. 286–292, Aug. 2014, doi: <a href="https://doi.org/10.1016/j.jhep.2014.03.034">10.1016/j.jhep.2014.03.034</a>.</p>
</div>
<div>
<p>[140] M. E. Grams <em>et al.</em>, “Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate,” <em>Kidney International</em>, vol. 93, no. 6, pp. 1442–1451, Jun. 2018, doi: <a href="https://doi.org/10.1016/j.kint.2018.01.009">10.1016/j.kint.2018.01.009</a>.</p>
</div>
<div>
<p>[141] R. A. Hoefield <em>et al.</em>, “Factors associated with kidney disease progression and mortality in a referred CKD population,” <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em>, vol. 56, no. 6, pp. 1072–1081, Dec. 2010, doi: <a href="https://doi.org/10.1053/j.ajkd.2010.06.010">10.1053/j.ajkd.2010.06.010</a>.</p>
</div>
<div>
<p>[142] R. Chinnadurai, C. Chrysochou, and P. A. Kalra, “Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease,” <em>Nephron</em>, vol. 141, no. 1, pp. 24–30, 2019, doi: <a href="https://doi.org/10.1159/000493472">10.1159/000493472</a>.</p>
</div>
<div>
<p>[143] A. S. Levey <em>et al.</em>, “A new equation to estimate glomerular filtration rate,” <em>Annals of Internal Medicine</em>, vol. 150, no. 9, pp. 604–612, May 2009, doi: <a href="https://doi.org/10.7326/0003-4819-150-9-200905050-00006">10.7326/0003-4819-150-9-200905050-00006</a>.</p>
</div>
<div>
<p>[144] J. P. New, N. D. Bakerly, D. Leather, and A. Woodcock, “Obtaining real-world evidence: The Salford Lung Study,” <em>Thorax</em>, vol. 69, pp. 1152–1154, 2014, doi: <a href="https://doi.org/http://dx.doi.org/10.1136/thoraxjnl-2014-205259">http://dx.doi.org/10.1136/thoraxjnl-2014-205259</a>.</p>
</div>
<div>
<p>[145] K. Matsushita <em>et al.</em>, “Cohort Profile: The Chronic Kidney Disease Prognosis Consortium,” <em>International Journal of Epidemiology</em>, vol. 42, no. 6, pp. 1660–1668, Dec. 2013, doi: <a href="https://doi.org/10.1093/ije/dys173">10.1093/ije/dys173</a>.</p>
</div>
<div>
<p>[146] I. R. White and P. Royston, “Imputing missing covariate values for the Cox model,” <em>Statistics in Medicine</em>, vol. 28, no. 15, pp. 1982–1998, Jul. 2009, doi: <a href="https://doi.org/10.1002/sim.3618">10.1002/sim.3618</a>.</p>
</div>
<div>
<p>[147] G. Venkat-Raman <em>et al.</em>, “New primary renal diagnosis codes for the ERA-EDTA,” <em>Nephrology Dialysis Transplantation</em>, vol. 27, no. 12, pp. 4414–4419, Dec. 2012, doi: <a href="https://doi.org/10.1093/ndt/gfs461">10.1093/ndt/gfs461</a>.</p>
</div>
<div>
<p>[148] C. P. Kovesdy <em>et al.</em>, “Past Decline Versus Current eGFR and Subsequent ESRD Risk,” <em>Journal of the American Society of Nephrology</em>, vol. 27, no. 8, pp. 2447–2455, Aug. 2016, doi: <a href="https://doi.org/10.1681/ASN.2015060687">10.1681/ASN.2015060687</a>.</p>
</div>
<div>
<p>[149] D. M. J. Naimark <em>et al.</em>, “Past Decline Versus Current eGFR and Subsequent Mortality Risk,” <em>Journal of the American Society of Nephrology</em>, vol. 27, no. 8, pp. 2456–2466, Aug. 2016, doi: <a href="https://doi.org/10.1681/ASN.2015060688">10.1681/ASN.2015060688</a>.</p>
</div>
<div>
<p>[150] P. M. Grambsch and T. M. Therneau, “Proportional Hazards Tests and Diagnostics Based on Weighted Residuals,” <em>Biometrika</em>, vol. 81, no. 3, pp. 515–526, 1994, doi: <a href="https://doi.org/10.2307/2337123">10.2307/2337123</a>.</p>
</div>
<div>
<p>[151] D. Schoenfeld, “Partial residuals for the proportional hazards regression model,” <em>Biometrika</em>, vol. 69, no. 1, pp. 239–241, Apr. 1982, doi: <a href="https://doi.org/10.1093/biomet/69.1.239">10.1093/biomet/69.1.239</a>.</p>
</div>
<div>
<p>[152] M. Schomaker and C. Heumann, “Bootstrap inference when using multiple imputation,” <em>Statistics in Medicine</em>, vol. 37, no. 14, pp. 2252–2266, 2018, doi: <a href="https://doi.org/10.1002/sim.7654">10.1002/sim.7654</a>.</p>
</div>
<div>
<p>[153] S. van Buuren and K. Groothuis-Oudshoorn, “Mice: Multivariate Imputation by Chained Equations in R,” <em>Journal of Statistical Software</em>, vol. 45, no. 1, pp. 1–67, Dec. 2011, doi: <a href="https://doi.org/10.18637/jss.v045.i03">10.18637/jss.v045.i03</a>.</p>
</div>
<div>
<p>[154] C. Jackson, “Flexsurv: A Platform for Parametric Survival Modelling in R,” p. 33.</p>
</div>
<div>
<p>[155] D. Vaughan and M. Dancho, “Furrr: Apply Mapping Functions in Parallel using Futures.” May-2018.</p>
</div>
<div>
<p>[156] S. Jivraj and O. Khan, “Ethnicity and deprivation in England: How likely are ethnic minorities to live in deprived neighbourhoods?” University of Manchester, Dec. 2013.</p>
</div>
<div>
<p>[157] Public Health England, “Salford Unitary Authority Health Profile 2017,” Jul. 2017.</p>
</div>
<div>
<p>[158] K. G. M. Moons, D. G. Altman, Y. Vergouwe, and P. Royston, “Prognosis and prognostic research: Application and impact of prognostic models in clinical practice,” <em>BMJ</em>, vol. 338, p. b606, Jun. 2009, doi: <a href="https://doi.org/10.1136/bmj.b606">10.1136/bmj.b606</a>.</p>
</div>
<div>
<p>[159] L. Meira-Machado, J. de Una-Alvarez, C. Cadarso-Suarez, and P. K. Andersen, “Multi-state models for the analysis of time-to-event data,” <em>Statistical methods in medical research</em>, vol. 18, no. 2, pp. 195–222, Apr. 2009, doi: <a href="https://doi.org/10.1177/0962280208092301">10.1177/0962280208092301</a>.</p>
</div>
<div>
<p>[160] A. M. Wood, I. R. White, and P. Royston, “How should variable selection be performed with multiply imputed data?” <em>Statistics in Medicine</em>, vol. 27, no. 17, pp. 3227–3246, Jul. 2008, doi: <a href="https://doi.org/10.1002/sim.3177">10.1002/sim.3177</a>.</p>
</div>
<div>
<p>[161] D. B. Rubin, <em>Multiple Imputation for Nonresponse in Surveys</em>. New York, NY: John Wiley &amp; Sons, Inc, 1984.</p>
</div>
<div>
<p>[162] K. J. M. Janssen <em>et al.</em>, “Dealing with missing predictor values when applying clinical prediction models,” <em>Clinical Chemistry</em>, vol. 55, no. 5, pp. 994–1001, May 2009, doi: <a href="https://doi.org/10.1373/clinchem.2008.115345">10.1373/clinchem.2008.115345</a>.</p>
</div>
<div>
<p>[163] T. Gneiting and A. E. Raftery, “Strictly Proper Scoring Rules, Prediction, and Estimation,” <em>Journal of the American Statistical Association</em>, vol. 102, no. 477, pp. 359–378, Mar. 2007, doi: <a href="https://doi.org/10.1198/016214506000001437">10.1198/016214506000001437</a>.</p>
</div>
</div>

</div>
            </section>

          </div>
        </div>
      </div>
<a href="chap-dev-paper-supp.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": [["thesis.pdf", "PDF"]],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
